JAM
TEVA icon

Jupiter Asset Management’s Teva Pharmaceuticals TEVA Stock Holding History

Jupiter Asset Management’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-73,173
Closed -$659K – 656
2020
Q3 		$659K Buy
+73,173
New +$774K 0.01% 493

Other funds holding TEVA

Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Berkshire Hathaway
Berkshire Hathaway Omaha, Nebraska $263B AUM 16.68% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $4.64B AUM 1.52% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $11.5B AUM 52.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return

Jupiter Asset Management's TEVA Position: Q4 2020 in Review

Jupiter Asset Management sold out of Teva Pharmaceuticals (TEVA) in Q4 2020, closing a stake of 73,173 shares — an estimated $659K sold.

Jupiter Asset Management first reported a position in TEVA in Q3 2020 and held it in 1 quarter. The position peaked at $659K in Q3 2020. 449 funds tracked by Wall St. Rank hold TEVA as of Q4 2020.

  • Jupiter Asset Management reported no remaining Teva Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
  • Jupiter Asset Management sold 73,173 Teva Pharmaceuticals shares in Q4 2020, an estimated $659K.
  • Jupiter Asset Management first reported a position in Teva Pharmaceuticals in Q3 2020 and held it in 1 quarter.
  • Jupiter Asset Management's Teva Pharmaceuticals position peaked at $659K in Q3 2020.
  • 449 funds tracked by Wall St. Rank held Teva Pharmaceuticals as of Q4 2020.

Based on Jupiter Asset Management's 13F filing for Q4 2020, filed 10 Feb 2021.